Latest News
Investors Watch Key Players in Oncology as Cancer Cases Set to Skyrocket
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – The surge in global cancer cases is raising...
By investing in these dividend powerhouses, investors can achieve reliable income, mitigate risk through diversification, and potentially enjoy capital gains.
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
For over a decade, these two drugmakers consistently outperformed the benchmark index and could do it again.
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
The dividend growth powerhouse is turning the corner.
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
Financial factors aren't the only things that are worth paying attention to.
3 Stocks to Buy and Hold Forever
These stocks are built for the long run.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Their dividends are solid. And their businesses are built for the long run.
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
The stock has been a winner, but there may be better times ahead for buying.
Health Canada Approves AbbVie's CONSTELLA® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients 6 to 17 Years of Age
/CNW/ - AbbVie (NYSE: ABBV), today announced that Health Canada has approved CONSTELLA® (linaclotide) as a once-daily oral treatment for children and...
3 Things You Need to Know if You Buy AbbVie Stock Today
This dynamic big pharma is undergoing a few key changes.
3 No-Brainer Dividend Stocks to Buy in September
These stocks pay great dividends and could be long-term winners.
Earn $1,000 Per Month in Dividends From These 4 Stocks
A mix of various types of dividend investments.
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
There is something for everybody in America's $4.5 trillion healthcare market.
With rate cuts expected later this month, these three dividend-focused ETFs can enhance your portfolio now.
AbbVie's VRAYLAR® (cariprazine) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for the Treatment of Schizophrenia
/CNW/ - AbbVie (NYSE: ABBV) today announced that Canada's Drug Agency (CDA, formerly CADTH) has recommended that VRAYLAR be reimbursed with conditions, for the...
2 Dividend Stocks You Can Safely Hold Through a Recession
These stocks can help you sleep peacefully at night, even in bad times.
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
A drugmaker and a telecom business have what it takes to safely boost your passive income stream.
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
These businesses can stand the test of time in a diversified portfolio.
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
These three have secure core businesses, plus multiple paths to grow.
2 Incredibly Cheap Healthcare Stocks to Buy Now
Top healthcare stocks are a great addition to any portfolio.
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
There are three operative words with these dividend stocks: buy and hold.
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
It'll be a while before there's any impact, but it could be a big deal.
Donald Trump Owns These 21 Dividend Kings. Should You?
Some of Trump's Dividend Kings deserve a crown more than others.
3 Unstoppable Dividend Stocks to Buy Right Now
These stocks are the A-team for income investors.